Country Trust Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $102K | Buy |
4,233
+251
| +6% | +$6.57K | ﹤0.01% | 162 |
|
|
2026
Q1 | $112K | Sell |
3,982
-641
| -14% | -$17.1K | ﹤0.01% | 146 |
|
|
2025
Q4 | $115K | Sell |
4,623
-300
| -6% | -$7.57K | ﹤0.01% | 152 |
|
|
2025
Q3 | $125K | Buy |
4,923
+460
| +10% | +$11.4K | ﹤0.01% | 154 |
|
|
2025
Q2 | $108K | Buy |
4,463
+1,263
| +39% | +$29.5K | ﹤0.01% | 161 |
|
|
2025
Q1 | $81.1K | Hold |
3,200
| – | – | ﹤0.01% | 160 |
|
|
2024
Q4 | $84.9K | Sell |
3,200
-1,500
| -32% | -$40.7K | ﹤0.01% | 158 |
|
|
2024
Q3 | $136K | Buy |
4,700
+1,500
| +47% | +$43.8K | ﹤0.01% | 138 |
|
|
2024
Q2 | $89.5K | Sell |
3,200
-50
| -2% | -$1.38K | ﹤0.01% | 141 |
|
|
2024
Q1 | $90.2K | Hold |
3,250
| – | – | ﹤0.01% | 146 |
|
|
2023
Q4 | $93.6K | Sell |
3,250
-3,332
| -51% | -$101K | ﹤0.01% | 139 |
|
|
2023
Q3 | $218K | Buy |
6,582
+881
| +15% | +$31.2K | 0.01% | 113 |
|
|
2023
Q2 | $209K | Buy |
5,701
+333
| +6% | +$13K | 0.01% | 112 |
|
|
2023
Q1 | $219K | Sell |
5,368
-1,925
| -26% | -$83.1K | 0.01% | 109 |
|
|
2022
Q4 | $374K | Sell |
7,293
-943
| -11% | -$45.2K | 0.01% | 105 |
|
|
2022
Q3 | $360K | Buy |
8,236
+139
| +2% | +$6.75K | 0.01% | 105 |
|
|
2022
Q2 | $425K | Hold |
8,097
| – | – | 0.01% | 103 |
|
|
2022
Q1 | $419K | Buy |
8,097
+1,848
| +30% | +$95.9K | 0.01% | 108 |
|
|
2021
Q4 | $369K | Sell |
6,249
-671
| -10% | -$33.2K | 0.01% | 117 |
|
|
2021
Q3 | $298K | Buy |
6,920
+1,992
| +40% | +$88.2K | 0.01% | 115 |
|
|
2021
Q2 | $193K | Buy |
4,928
+183
| +4% | +$7.12K | 0.01% | 131 |
|
|
2021
Q1 | $172K | Sell |
4,745
-182,561
| -97% | -$6.48M | 0.01% | 136 |
|
|
2020
Q4 | $6.89M | Sell |
187,306
-295,072
| -61% | -$10.8M | 0.24% | 77 |
|
|
2020
Q3 | $16.8M | Sell |
482,378
-40,188
| -8% | -$1.41M | 0.64% | 64 |
|
|
2020
Q2 | $16.2M | Buy |
522,566
+20,566
| +4% | +$699K | 0.65% | 60 |
|
|
2020
Q1 | $15.5M | Buy |
502,000
+11,079
| +2% | +$378K | 0.7% | 58 |
|
|
2019
Q4 | $18.2M | Sell |
490,921
-6,693
| -1% | -$238K | 0.72% | 59 |
|
|
2019
Q3 | $17M | Buy |
497,614
+4,686
| +1% | +$170K | 0.73% | 58 |
|
|
2019
Q2 | $20.3M | Buy |
492,928
+22,438
| +5% | +$891K | 0.88% | 48 |
|
|
2019
Q1 | $19M | Buy |
470,490
+16,454
| +4% | +$659K | 0.84% | 55 |
|
|
2018
Q4 | $18.8M | Buy |
454,036
+992
| +0.2% | +$41.2K | 0.94% | 48 |
|
|
2018
Q3 | $18.9M | Sell |
453,044
-423,097
| -48% | -$16.3M | 0.88% | 53 |
|
|
2018
Q2 | $30.2M | Buy |
876,141
+4,115
| +0.5% | +$141K | 1.29% | 30 |
|
|
2018
Q1 | $29.4M | Sell |
872,026
-103,909
| -11% | -$3.57M | 1.4% | 26 |
|
|
2017
Q4 | $33.5M | Buy |
975,935
+126,217
| +15% | +$4.3M | 1.44% | 26 |
|
|
2017
Q3 | $28.8M | Sell |
849,718
-603
| -0.1% | -$19.4K | 1.3% | 30 |
|
|
2017
Q2 | $27.1M | Buy |
850,321
+4,092
| +0.5% | +$129K | 1.3% | 31 |
|
|
2017
Q1 | $27.5M | Buy |
846,229
+11,934
| +1% | +$376K | 1.37% | 32 |
|
|
2016
Q4 | $25.7M | Buy |
834,295
+12,449
| +2% | +$380K | 1.31% | 32 |
|
|
2016
Q3 | $26.4M | Sell |
821,846
-1,112
| -0.1% | -$37.2K | 1.37% | 30 |
|
|
2016
Q2 | $27.5M | Sell |
822,958
-7,572
| -0.9% | -$242K | 1.48% | 25 |
|
|
2016
Q1 | $23.4M | Sell |
830,530
-27,711
| -3% | -$792K | 1.25% | 33 |
|
|
2015
Q4 | $26.3M | Sell |
858,241
-366
| -0% | -$11.5K | 1.44% | 32 |
|
|
2015
Q3 | $25.6M | Buy |
858,607
+38,338
| +5% | +$1.23M | 1.4% | 30 |
|
|
2015
Q2 | $26.1M | Sell |
820,269
-298,670
| -27% | -$9.73M | 1.31% | 34 |
|
|
2015
Q1 | $36.9M | Buy |
1,118,939
+9,064
| +0.8% | +$288K | 1.86% | 12 |
|
|
2014
Q4 | $32.8M | Buy |
1,109,875
+4,864
| +0.4% | +$139K | 1.64% | 18 |
|
|
2014
Q3 | $31M | Buy |
1,105,011
+387,144
| +54% | +$10.9M | 1.59% | 18 |
|
|
2014
Q2 | $20.2M | Buy |
+717,867
| New | +$20.5M | 1.01% | 46 |
|
Other funds holding PFE
Country Trust Bank's PFE Position: Q2 2026 in Review
Country Trust Bank increased its Pfizer (PFE) stake by 6.3% in Q2 2026, buying an estimated $6.57K and bringing the position to 4,233 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #162.
Country Trust Bank first reported a position in PFE in Q2 2014 and has held it in 49 quarters since. The position peaked at $36.9M in Q1 2015. 2,255 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Country Trust Bank held 4,233 shares of Pfizer worth $102K as of Q2 2026.
- Country Trust Bank bought 251 Pfizer shares in Q2 2026, an estimated $6.57K.
- Pfizer made up ﹤0.01% of Country Trust Bank's portfolio in Q2 2026, its #162 holding.
- Country Trust Bank first reported a position in Pfizer in Q2 2014 and has held it in 49 quarters since.
- Country Trust Bank's Pfizer position peaked at $36.9M in Q1 2015.
- 2,255 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.